Navigation Links
Premier Research Names Etienne Drouet Executive Director, Oncology Europe
Date:1/23/2012

PHILADELPHIA, Jan. 23, 2012 /PRNewswire/ -- Premier Research Group announces the appointment of Etienne Drouet to the position of Executive Director, Oncology Europe. In this position, Mr. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research's growing portfolio of oncology business.

"Etienne brings a tremendous amount of operational knowledge and oncology acumen serving the needs of our customers," said Dr. Sue Stansfield, Executive VP, Clinical Development.  Dr. Ludo Reynders added, "Having worked with Etienne before, I am pleased to have someone of his caliber lead our European oncology team."

Mr. Drouet offers practical insight to oncology clinical trials with more than 19 years in drug development including 14 years in clinical research and five years as a research scientist. Mr. Drouet has held positions of increasing responsibility at pharmaceutical, contract research, and investigational cooperative groups including Rhone Poulenc Rorer (Sanofi Aventis), Icon, and Breast Cancer International Research Group. His extensive oncology experience and expertise has ensured timely, efficient program delivery. He holds a Biotechnology Engineering degree from the European Engineering School of Biotechnology and a Master in Science degree from the University Louis Pasteur.

About Premier Research
Premier Research is a professional services company providing clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide.  The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it provides a strong strategic sourcing group that supports customers in their resource planning and management.

The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.

For more information please visit, www.premier-research.com.

 

    


'/>"/>
SOURCE Premier Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development
2. "Wells Pharmacy Network" a Premier Compounding Pharmacy Focused on Serving the Unique Needs of the Medical and Veterinarian Communities Opens in Wellington
3. The Huntington Medical Foundation -- Pasadenas Premier Medical Group
4. SurgiCount Medical Announces Agreement with Premier Healthcare Alliance
5. White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
6. SensoScientific Awarded Contract by Premier Health Care Alliance for its Breakthrough WI-FI Temperature Monitoring System
7. MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
8. Qmed - The Premier Source for OEMs Seeking Suppliers and Products in Medical Device Industry - Reconfirms its Leadership with the Highest Traffic Month to Date
9. Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management
10. Premier Awards Sixth Consecutive Contract to Instrumentation Laboratory for Critical Care Portfolio
11. ARKRAY Awarded Blood Glucose Meters Agreement With the Premier Healthcare Alliance for Non-Acute Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/11/2017)... IRVINE, Calif. , July 11, 2017 Zymo Research Corp., ... new service that can quantify biological aging in a precise manner using ... Dr. Steve Horvath , a professor of human genetics and biostatistics ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... loci. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the launch ... for colleges and universities at the APPA 2017 Annual Conference and Exhibition ... tobacco smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke Away ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... The Margarian ... falsely advertising the contents of its ginger ale for allegedly containing no ginger. Dr. ... Dr. Pepper Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims ...
(Date:7/21/2017)... ... 21, 2017 , ... “Kids aren't born knowing how to regulate their emotions ... Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help with that ... July 21st. , The kit uses colorful, engaging and educational illustrations and games ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
Breaking Medicine News(10 mins):